Relmada Therapeutics Inc. buy BiotechBee
Start price
07.09.22
/
60%
€30.00
Target price
31.12.24
€45.00
Performance (%)
-79.00%
End price
14.10.22
€6.30
Summary
This prediction ended on 14.10.22 with a price of €6.30. Massive losses of -79.00% were the result for the BUY prediction by BiotechBee. BiotechBee has 60% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Relmada Therapeutics Inc. | - | - | - |
iShares Core DAX® | 2.594% | -1.158% | 14.782% |
iShares Nasdaq 100 | 3.553% | -1.727% | 43.265% |
iShares Nikkei 225® | 0.687% | -8.354% | 18.454% |
iShares S&P 500 | 2.209% | -0.942% | 31.361% |
According to BiotechBee what are the pros and cons of Relmada Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Relmada Therapeutics Inc. diskutieren
Buy mit Kursziel 45,0
In the thread Trading Relmada Therapeutics Inc.
Buy beendet
Stopped prediction by BiotechBee for Relmada Therapeutics Inc.
Relmada Therapeutics Inc.
Start price
Target price
Perf. (%)
€3.46
03.09.23
03.09.23
€5.00
31.12.25
31.12.25
-2.31%
06.09.23
06.09.23
Could be very worthwhile Investment >20% year